Antimicrobial peptide GL13K immobilized onto SLA-treated titanium by silanization: antibacterial effect against

Yusang Li1, Ruiying Chen2, Fushi Wang1,3

  • 1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University Wuhan China xinjie.cai@whu.edu.cn wang.yn@whu.edu.cn.

RSC Advances
|April 15, 2022
PubMed

Insights

A novel antimicrobial peptide coating, GL13K, on titanium implants effectively combats drug-resistant bacteria like MRSA. This coating shows strong antibacterial activity and good biocompatibility, offering a promising alternative to antibiotics for preventing implant infections.

Area of Science:

  • Biomaterials Science
  • Infectious Diseases
  • Nanotechnology

Background:

  • Implant failure due to bacterial infection, particularly from antibiotic-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA), is a significant clinical challenge.
  • Conventional antibiotics are becoming less effective against resistant bacteria, necessitating the development of alternative strategies.

Purpose of the Study:

  • To develop and evaluate a novel antimicrobial peptide coating (GL13K) on sandblasted and acid-etched (SLA) titanium implants for combating drug-resistant bacterial infections.
  • To assess the antibacterial efficacy, release profile, and cytocompatibility of the SLA-GL13K coating.

Main Methods:

  • Fabrication of GL13K coating on SLA-treated titanium using a silane coupling agent.
  • Characterization of the coating's morphology, chemical composition, and hydrophilicity using field emission scanning electron microscopy, attenuated total reflectance Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy, and water contact angle analysis.
  • Evaluation of GL13K release profile, antibacterial activity against MRSA, E. coli, and S. aureus, and cytocompatibility using Cell Counting Kit 8 assays.

Main Results:

  • The SLA-GL13K coating was successfully fabricated and characterized, confirming GL13K loading and altered surface properties.
  • The coating demonstrated a sustained release of GL13K.
  • SLA-GL13K coating exhibited potent contact- and release-killing effects against MRSA, E. coli, and S. aureus.
  • The coating showed good cytocompatibility at effective antibacterial concentrations.

Conclusions:

  • Silanization is an effective method for fabricating GL13K coatings on SLA-treated titanium implants.
  • The SLA-GL13K coating presents a promising strategy for preventing and treating implant-related infections, particularly those caused by MRSA.